Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

Phase 3

Completed

• Conditions: Substance-Related Disorders

• Registration Number: NCT00032981
• Lead Sponsor: Yale University

Brief Summary

The purpose of this study is to evaluate the therapeutic usefulness of incorporating Motivational Enhancement Treatment into the standard drug abuse treatment entry process of Community Treatment Programs on improving treatment engagement, retention, and outcome.

Detailed Description

Participants seeking treatment at the participating CTPs will be randomly assigned to either "standard" or "MET/MI" treatment, with a 1- and 3-month follow-up. Primary outcome measures will include (1) treatment retention (e.g., number of sessions/weeks completed, the rate of patients completing 3 or more subsequent sessions, and (2) substance use (e.g., urinalyses, days of opioid, cocaine, marijuana, alcohol use, rates of abstinence). Secondary outcomes will include motivation, psychosocial functioning, HIV risk behaviors, treatment utilization, and patient satisfaction. Process assessments will include measures of the working alliance as well as therapist adherence/competence ratings which will evaluate how effectively MET/MI was implemented. Participating CTPs will implement one of two independent protocols, depending on which is the best suited or feasible for the intake procedures at their clinic. Thus, following an invitation to participate, explanation of the study, and provision of informed consent, patients would complete a brief assessment battery followed by either: 1) Random assignment to 3 individual sessions of standard treatment (treatment as usual) at the program versus 3 individual sessions of MET. or 2) Random assignment to 1 individual standard assessment/evaluation session.

Study Timeline

• Study Start: 2001-05
• Study First Submitted: 2002-04-05
• Study First Submitted QC: 2002-04-05
• Study First Posted: 2002-04-08
• Primary Completion: 2004-08
• Study Completion: 2004-08
• Status Verified: 2010-04
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 561

Inclusion Criteria

Individuals will be eligible for the protocol who:

• Are seeking outpatient treatment for any substance use disorder
• Are willing to participate in the protocol (e.g., to be randomized to treatment, be contacted for follow-up assessment, to have their sessions audiotaped)
• Are able to understand and provide written informed consent

Exclusion Criteria

Individuals will be excluded who:

• Are not sufficiently medically or psychiatrically stable to participate in outpatient treatment
• Are seeking detoxification only, methadone maintenance treatment or residential inpatient treatment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Psychosocial functioning
Drug use
HIV risk behaviors
Retention

Trial Locations

Locations (6)

Tarzana Treatment Center; 🇺🇸 Tarzana, California, United States

CT Renaissance, Inc.; 🇺🇸 Norwalk, Connecticut, United States

Haight Ashbury Free Clinics; 🇺🇸 San Francisco, California, United States

LMG Programs, Inc.; 🇺🇸 Stamford, Connecticut, United States

Rehab After Work; 🇺🇸 Philadelphia, Pennsylvania, United States

Northeast Treatment Center; 🇺🇸 Philadelphia, Pennsylvania, United States